Penn Capital Management Company, LLC Travere Therapeutics, Inc. Put Options Transaction History
Penn Capital Management Company, LLC
- $914 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TVTX
# of Institutions
234Shares Held
99.3MCall Options Held
1.57MPut Options Held
555K-
Armistice Capital, LLC New York, NY8.87MShares$190 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$164 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$161 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$107 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$103 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.37B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...